Up Another 13% 23 hours ago Shares of HIMS are up another 13%, or by $3.10, on news that Novo Nordisk agreed to distribute its products through the Hims platform, ending a longstanding feud between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results